Gender, medication use, and education: Key factors affecting motor development in toddlers under epilepsy treatment

Mustafa Bostanci1, Ayşe Güler Küçükturan2

  • 1Bursa Uludag University Hospital, Child Development Department Bursa, Turkey.

Insights

Longer antiepileptic drug use in children with epilepsy is linked to delays in psychomotor skills. However, increased education duration can positively impact these skills, potentially mitigating medication effects.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Clinical Pharmacy

Background:

  • Epilepsy affects children's development, with antiepileptic drugs (AEDs) potentially influencing psychomotor skills.
  • Understanding factors like medication duration and education is crucial for optimizing developmental outcomes in children with epilepsy.

Purpose of the Study:

  • To investigate the impact of gender, AED duration, and education on psychomotor skills in 24-36-month-old children with epilepsy.
  • To identify potential mitigating factors for developmental delays associated with epilepsy and its treatment.

Main Methods:

  • A cross-sectional survey of 173 children (24-36 months) diagnosed with epilepsy and on AEDs.
  • Utilized the Denver II Developmental Screening Test for data collection.
  • Employed Independent Sample t-test and ANOVA for statistical analysis, with eta squared for effect size.

Main Results:

  • No significant gender-based differences in fine or gross motor skills were observed.
  • Increased duration of AED use correlated with delays in both fine and gross motor skills (moderate effect).
  • Higher educational levels were associated with improved fine and gross motor skills, particularly for gross motor function.

Conclusions:

  • Long-term AED use may lead to psychomotor skill delays in young children with epilepsy.
  • Educational status and duration of education appear to mitigate these delays, especially for gross motor skills.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...